Paul A. Mahon, EVP and General Counsel of United Therapeutics Corp (UTHR), sold shares on the open market 173 times over the last 365 days, totaling $100.6 million. His most recent sale occurred on March 5, 2026. These sales rank him 163rd among 11,678 insiders by total value sold, well above the average of $8.6 million per insider and 6 transactions. Mahon made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1115 | $564.55 | 50,347.0000 | 48,100,000 | 2.17% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 371 | $563.58 | 51,462.0000 | 48,100,000 | 0.72% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 774 | $562.34 | 51,833.0000 | 48,100,000 | 1.47% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 351 | $561.69 | 52,607.0000 | 48,100,000 | 0.66% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 514 | $560.30 | 52,958.0000 | 48,100,000 | 0.96% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8300 | $146.03 | 53,472.0000 | 48,100,000 | 18.37% | 0.02% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 8300 | $0.00 | 16,900.0000 | 48,100,000 | 32.94% | 0.02% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $571.61 | 45,172.0000 | 48,100,000 | 0.44% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 710 | $569.61 | 45,372.0000 | 48,100,000 | 1.54% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 690 | $568.79 | 46,082.0000 | 48,100,000 | 1.48% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1403 | $567.55 | 46,772.0000 | 48,100,000 | 2.91% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1629 | $566.66 | 48,175.0000 | 48,100,000 | 3.27% | 0.00% |
| April 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 543 | $565.66 | 49,804.0000 | 48,100,000 | 1.08% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2808 | $529.82 | 48,472.0000 | 48,100,000 | 5.48% | 0.01% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 794 | $531.62 | 45,902.0000 | 48,100,000 | 1.70% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 650 | $532.50 | 45,252.0000 | 48,100,000 | 1.42% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 80 | $533.41 | 45,172.0000 | 48,100,000 | 0.18% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 8300 | $0.00 | 25,200.0000 | 48,100,000 | 24.78% | 0.02% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8300 | $146.03 | 53,472.0000 | 48,100,000 | 18.37% | 0.02% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 753 | $527.47 | 52,719.0000 | 48,100,000 | 1.41% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1439 | $528.41 | 51,280.0000 | 48,100,000 | 2.73% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1776 | $530.63 | 46,696.0000 | 48,100,000 | 3.66% | 0.00% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8895 | $0.00 | 45,739.0000 | 48,100,000 | 24.14% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7796 | $0.00 | 53,535.0000 | 48,100,000 | 17.04% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | F | Common Stock | 4457 | $536.12 | 49,078.0000 | 48,100,000 | 8.33% | 0.01% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | F | Common Stock | 3906 | $536.12 | 45,172.0000 | 48,100,000 | 7.96% | 0.01% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Restricted Stock Units | 8895 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Restricted Stock Units | 7796 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8300 | $146.03 | 45,144.0000 | 48,100,000 | 22.53% | 0.02% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 743 | $486.52 | 37,044.0000 | 48,100,000 | 1.97% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1006 | $485.32 | 37,787.0000 | 48,100,000 | 2.59% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1398 | $484.55 | 38,793.0000 | 48,100,000 | 3.48% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1086 | $483.54 | 40,191.0000 | 48,100,000 | 2.63% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1177 | $482.68 | 41,277.0000 | 48,100,000 | 2.77% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 720 | $481.33 | 42,454.0000 | 48,100,000 | 1.67% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1602 | $480.22 | 43,174.0000 | 48,100,000 | 3.58% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 8300 | $0.00 | 33,500.0000 | 48,100,000 | 19.86% | 0.02% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 368 | $479.43 | 44,776.0000 | 48,100,000 | 0.82% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $487.65 | 36,844.0000 | 48,100,000 | 0.54% | 0.00% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | A | Restricted Stock Units | 8895 | $0.00 | 8,895.0000 | 48,500,000 | 9999.99% | 0.02% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | A | Restricted Stock Units | 7796 | $0.00 | 7,796.0000 | 48,500,000 | 9999.99% | 0.02% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | A | Stock Options | 49860 | $0.00 | 49,860.0000 | 48,500,000 | 9999.99% | 0.10% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 775 | $472.76 | 43,690.0000 | 48,100,000 | 1.74% | 0.00% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2100 | $478.15 | 38,248.0000 | 48,100,000 | 5.20% | 0.00% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1467 | $478.92 | 36,781.0000 | 48,100,000 | 3.84% | 0.00% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 8300 | $0.00 | 41,800.0000 | 48,100,000 | 16.57% | 0.02% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1114 | $477.10 | 40,348.0000 | 48,100,000 | 2.69% | 0.00% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 881 | $475.89 | 41,462.0000 | 48,100,000 | 2.08% | 0.00% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1059 | $475.09 | 42,343.0000 | 48,100,000 | 2.44% | 0.00% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 288 | $473.23 | 43,402.0000 | 48,100,000 | 0.66% | 0.00% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8300 | $146.03 | 45,081.0000 | 48,100,000 | 22.57% | 0.02% |
| Feb. 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 616 | $471.36 | 44,465.0000 | 48,100,000 | 1.37% | 0.00% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1103 | $482.57 | 41,138.0000 | 48,100,000 | 2.61% | 0.00% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 8300 | $0.00 | 50,100.0000 | 48,100,000 | 14.21% | 0.02% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 675 | $485.52 | 36,781.0000 | 48,100,000 | 1.80% | 0.00% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 934 | $484.92 | 37,456.0000 | 48,100,000 | 2.43% | 0.00% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2748 | $483.92 | 38,390.0000 | 48,100,000 | 6.68% | 0.01% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2363 | $481.93 | 42,241.0000 | 48,100,000 | 5.30% | 0.00% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 477 | $480.92 | 44,604.0000 | 48,100,000 | 1.06% | 0.00% |
| Feb. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8300 | $146.03 | 45,081.0000 | 48,100,000 | 22.57% | 0.02% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 8300 | $0.00 | 58,400.0000 | 48,100,000 | 12.44% | 0.02% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 40 | $474.74 | 36,781.0000 | 48,100,000 | 0.11% | 0.00% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1576 | $471.44 | 36,821.0000 | 48,100,000 | 4.10% | 0.00% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3531 | $469.34 | 38,397.0000 | 48,100,000 | 8.42% | 0.01% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 407 | $472.28 | 41,928.0000 | 48,100,000 | 0.96% | 0.00% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1307 | $470.37 | 42,335.0000 | 48,100,000 | 2.99% | 0.00% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1439 | $468.32 | 43,642.0000 | 48,100,000 | 3.19% | 0.00% |
| Jan. 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8300 | $146.03 | 45,081.0000 | 48,100,000 | 22.57% | 0.02% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 8300 | $146.03 | 45,081.0000 | 48,100,000 | 22.57% | 0.02% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $489.15 | 36,781.0000 | 48,100,000 | 0.54% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2181 | $487.76 | 36,981.0000 | 48,100,000 | 5.57% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1130 | $486.85 | 39,162.0000 | 48,100,000 | 2.80% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1509 | $485.68 | 40,292.0000 | 48,100,000 | 3.61% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1240 | $484.54 | 41,801.0000 | 48,100,000 | 2.88% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 739 | $483.35 | 43,041.0000 | 48,100,000 | 1.69% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 479 | $481.83 | 43,780.0000 | 48,100,000 | 1.08% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 822 | $481.26 | 44,259.0000 | 48,100,000 | 1.82% | 0.00% |
| Jan. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 8300 | $0.00 | 66,700.0000 | 48,100,000 | 11.07% | 0.02% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 9,250.0000 | 48,100,000 | 54.32% | 0.02% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 502 | $509.22 | 47,279.0000 | 48,100,000 | 1.05% | 0.00% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 138 | $509.81 | 47,141.0000 | 48,100,000 | 0.29% | 0.00% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 40 | $510.64 | 47,101.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2877 | $512.59 | 44,224.0000 | 48,100,000 | 6.11% | 0.01% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 4713 | $513.46 | 39,511.0000 | 48,100,000 | 10.66% | 0.01% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2650 | $514.18 | 36,861.0000 | 48,100,000 | 6.71% | 0.01% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 80 | $516.06 | 36,781.0000 | 48,100,000 | 0.22% | 0.00% |
| Dec. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $146.03 | 47,781.0000 | 48,100,000 | 29.91% | 0.02% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $146.03 | 47,781.0000 | 48,100,000 | 29.91% | 0.02% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 20,250.0000 | 48,100,000 | 35.20% | 0.02% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 400 | $487.37 | 36,781.0000 | 48,100,000 | 1.08% | 0.00% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1116 | $486.36 | 37,181.0000 | 48,100,000 | 2.91% | 0.00% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2804 | $485.22 | 38,297.0000 | 48,100,000 | 6.82% | 0.01% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 5220 | $484.31 | 41,101.0000 | 48,100,000 | 11.27% | 0.01% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 900 | $483.25 | 46,321.0000 | 48,100,000 | 1.91% | 0.00% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 560 | $482.22 | 47,221.0000 | 48,100,000 | 1.17% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1277 | $488.13 | 36,781.0000 | 48,100,000 | 3.36% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3350 | $487.21 | 38,058.0000 | 48,100,000 | 8.09% | 0.01% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1923 | $486.23 | 41,408.0000 | 48,100,000 | 4.44% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2210 | $485.15 | 43,331.0000 | 48,100,000 | 4.85% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1727 | $484.20 | 45,541.0000 | 48,100,000 | 3.65% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 513 | $483.05 | 47,268.0000 | 48,100,000 | 1.07% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,100,000 | 29.91% | 0.02% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1063 | $458.16 | 46,518.0000 | 48,100,000 | 2.23% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $456.39 | 47,581.0000 | 48,100,000 | 0.42% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,100,000 | 29.91% | 0.02% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 17 | $469.09 | 36,781.0000 | 48,100,000 | 0.05% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2070 | $468.48 | 36,798.0000 | 48,100,000 | 5.33% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1992 | $467.37 | 38,868.0000 | 48,100,000 | 4.88% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 884 | $466.24 | 40,860.0000 | 48,100,000 | 2.12% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 776 | $465.37 | 41,744.0000 | 48,100,000 | 1.83% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1979 | $464.19 | 42,520.0000 | 48,100,000 | 4.45% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 979 | $463.32 | 44,499.0000 | 48,100,000 | 2.15% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1040 | $461.36 | 45,478.0000 | 48,100,000 | 2.24% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 11,000.0000 | 48,100,000 | 50.00% | 0.02% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 22,000.0000 | 48,100,000 | 33.33% | 0.02% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,100,000 | 29.91% | 0.02% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 393 | $454.15 | 36,781.0000 | 48,100,000 | 1.06% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1285 | $452.33 | 37,174.0000 | 48,100,000 | 3.34% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1849 | $451.57 | 38,459.0000 | 48,100,000 | 4.59% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2247 | $450.64 | 40,308.0000 | 48,100,000 | 5.28% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3441 | $449.46 | 42,555.0000 | 48,100,000 | 7.48% | 0.01% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1143 | $448.56 | 45,996.0000 | 48,100,000 | 2.42% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 642 | $447.34 | 47,139.0000 | 48,100,000 | 1.34% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,100,000 | 29.91% | 0.02% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 33,000.0000 | 48,100,000 | 25.00% | 0.02% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1 | $435.42 | 36,781.0000 | 48,100,000 | 0.00% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 798 | $434.76 | 36,782.0000 | 48,100,000 | 2.12% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1652 | $433.45 | 37,580.0000 | 48,100,000 | 4.21% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2078 | $432.59 | 39,232.0000 | 48,100,000 | 5.03% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2516 | $431.72 | 41,310.0000 | 48,100,000 | 5.74% | 0.01% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 955 | $430.59 | 43,826.0000 | 48,100,000 | 2.13% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1092 | $429.61 | 44,781.0000 | 48,100,000 | 2.38% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1908 | $428.51 | 45,873.0000 | 48,100,000 | 3.99% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,100,000 | 29.91% | 0.02% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1430 | $433.72 | 46,351.0000 | 48,100,000 | 2.99% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1828 | $435.22 | 44,523.0000 | 48,100,000 | 3.94% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1881 | $436.24 | 42,642.0000 | 48,100,000 | 4.22% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3136 | $437.15 | 39,506.0000 | 48,100,000 | 7.35% | 0.01% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1905 | $438.17 | 37,601.0000 | 48,100,000 | 4.82% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 346 | $439.19 | 37,255.0000 | 48,100,000 | 0.92% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 474 | $440.16 | 36,781.0000 | 48,100,000 | 1.27% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 44,000.0000 | 48,100,000 | 20.00% | 0.02% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 400 | $402.50 | 47,381.0000 | 48,500,000 | 0.84% | 0.00% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1100 | $404.33 | 46,281.0000 | 48,500,000 | 2.32% | 0.00% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2973 | $405.45 | 43,308.0000 | 48,500,000 | 6.42% | 0.01% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3222 | $406.39 | 40,086.0000 | 48,500,000 | 7.44% | 0.01% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2105 | $407.42 | 37,981.0000 | 48,500,000 | 5.25% | 0.00% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1200 | $408.11 | 36,781.0000 | 48,500,000 | 3.16% | 0.00% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 55,000.0000 | 48,500,000 | 16.67% | 0.02% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 275 | $384.90 | 42,756.0000 | 48,500,000 | 0.64% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1499 | $386.51 | 41,257.0000 | 48,500,000 | 3.51% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1128 | $387.41 | 40,129.0000 | 48,500,000 | 2.73% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 850 | $387.86 | 39,279.0000 | 48,500,000 | 2.12% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 66,000.0000 | 48,500,000 | 14.29% | 0.02% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $396.54 | 36,781.0000 | 48,500,000 | 0.54% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 98 | $392.03 | 36,981.0000 | 48,500,000 | 0.26% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 400 | $390.46 | 37,079.0000 | 48,500,000 | 1.07% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1800 | $389.16 | 37,479.0000 | 48,500,000 | 4.58% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 499 | $379.47 | 47,282.0000 | 48,500,000 | 1.04% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1266 | $380.62 | 46,016.0000 | 48,500,000 | 2.68% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2335 | $381.58 | 43,681.0000 | 48,500,000 | 5.07% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 350 | $382.21 | 43,331.0000 | 48,500,000 | 0.80% | 0.00% |
| Sept. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 300 | $383.28 | 43,031.0000 | 48,500,000 | 0.69% | 0.00% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 4234 | $309.43 | 38,876.0000 | 48,500,000 | 9.82% | 0.01% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2330 | $308.43 | 43,110.0000 | 48,500,000 | 5.13% | 0.00% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1441 | $307.39 | 45,440.0000 | 48,500,000 | 3.07% | 0.00% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 300 | $306.12 | 46,881.0000 | 48,500,000 | 0.64% | 0.00% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 600 | $304.57 | 47,181.0000 | 48,500,000 | 1.26% | 0.00% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 77,000.0000 | 48,500,000 | 12.50% | 0.02% |
| Aug. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2095 | $310.25 | 36,781.0000 | 48,500,000 | 5.39% | 0.00% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2918 | $299.48 | 42,119.0000 | 48,500,000 | 6.48% | 0.01% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1353 | $298.73 | 45,037.0000 | 48,500,000 | 2.92% | 0.00% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1401 | $301.67 | 37,881.0000 | 48,500,000 | 3.57% | 0.00% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1000 | $302.70 | 36,881.0000 | 48,500,000 | 2.64% | 0.00% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 100 | $303.45 | 36,781.0000 | 48,500,000 | 0.27% | 0.00% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 88,000.0000 | 48,500,000 | 11.11% | 0.02% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1391 | $297.49 | 46,390.0000 | 48,500,000 | 2.91% | 0.00% |
| Aug. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2837 | $300.47 | 39,282.0000 | 48,500,000 | 6.74% | 0.01% |
| July 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3769 | $303.31 | 44,012.0000 | 48,500,000 | 7.89% | 0.01% |
| July 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 4977 | $304.25 | 39,035.0000 | 48,500,000 | 11.31% | 0.01% |
| July 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2254 | $305.14 | 36,781.0000 | 48,500,000 | 5.77% | 0.00% |
| July 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 99,000.0000 | 48,500,000 | 10.00% | 0.02% |
| July 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| July 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1358 | $301.20 | 36,781.0000 | 48,500,000 | 3.56% | 0.00% |
| July 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 7738 | $300.48 | 38,139.0000 | 48,500,000 | 16.87% | 0.02% |
| July 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| July 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 110,000.0000 | 48,500,000 | 9.09% | 0.02% |
| July 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1304 | $299.49 | 45,877.0000 | 48,500,000 | 2.76% | 0.00% |
| July 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 600 | $297.89 | 47,181.0000 | 48,500,000 | 1.26% | 0.00% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 121,000.0000 | 48,500,000 | 8.33% | 0.02% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1150 | $287.92 | 36,881.0000 | 48,500,000 | 3.02% | 0.00% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 100 | $288.80 | 36,781.0000 | 48,500,000 | 0.27% | 0.00% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2334 | $287.21 | 38,031.0000 | 48,500,000 | 5.78% | 0.00% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 939 | $286.13 | 40,365.0000 | 48,500,000 | 2.27% | 0.00% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3940 | $285.01 | 41,304.0000 | 48,500,000 | 8.71% | 0.01% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2537 | $284.10 | 45,244.0000 | 48,500,000 | 5.31% | 0.01% |
| June 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1837 | $278.41 | 44,338.0000 | 48,500,000 | 3.98% | 0.00% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 506 | $275.98 | 47,275.0000 | 48,500,000 | 1.06% | 0.00% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $135.42 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1425 | $279.51 | 42,913.0000 | 48,500,000 | 3.21% | 0.00% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1375 | $280.70 | 41,538.0000 | 48,500,000 | 3.20% | 0.00% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 4557 | $281.56 | 36,981.0000 | 48,500,000 | 10.97% | 0.01% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $282.27 | 36,781.0000 | 48,500,000 | 0.54% | 0.00% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 132,000.0000 | 48,500,000 | 7.69% | 0.02% |
| June 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1100 | $276.95 | 46,175.0000 | 48,500,000 | 2.33% | 0.00% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 99 | $311.14 | 43,682.0000 | 48,500,000 | 0.23% | 0.00% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7000 | $135.42 | 43,781.0000 | 48,500,000 | 19.03% | 0.01% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 4000 | $117.76 | 47,781.0000 | 48,500,000 | 9.14% | 0.01% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 4000 | $315.77 | 43,781.0000 | 48,500,000 | 8.37% | 0.01% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 101 | $313.46 | 43,581.0000 | 48,500,000 | 0.23% | 0.00% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1703 | $315.53 | 41,878.0000 | 48,500,000 | 3.91% | 0.00% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 4573 | $316.57 | 37,305.0000 | 48,500,000 | 10.92% | 0.01% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 524 | $317.19 | 36,781.0000 | 48,500,000 | 1.40% | 0.00% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 7000 | $0.00 | 143,000.0000 | 48,500,000 | 4.67% | 0.01% |
| May 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 4000 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.01% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 4,000.0000 | 48,500,000 | 73.33% | 0.02% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $117.76 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2139 | $293.31 | 45,642.0000 | 48,500,000 | 4.48% | 0.00% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1104 | $293.96 | 44,538.0000 | 48,500,000 | 2.42% | 0.00% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 5004 | $295.10 | 39,534.0000 | 48,500,000 | 11.24% | 0.01% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1744 | $296.41 | 37,790.0000 | 48,500,000 | 4.41% | 0.00% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 800 | $297.33 | 36,990.0000 | 48,500,000 | 2.12% | 0.00% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 4 | $299.00 | 36,986.0000 | 48,500,000 | 0.01% | 0.00% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 203 | $300.24 | 36,783.0000 | 48,500,000 | 0.55% | 0.00% |
| May 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2 | $302.02 | 36,781.0000 | 48,500,000 | 0.01% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1320 | $300.63 | 44,152.0000 | 48,500,000 | 2.90% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $117.76 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 870 | $295.12 | 46,911.0000 | 48,500,000 | 1.82% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 400 | $296.00 | 46,511.0000 | 48,500,000 | 0.85% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 239 | $297.00 | 46,272.0000 | 48,500,000 | 0.51% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 300 | $298.05 | 45,972.0000 | 48,500,000 | 0.65% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 500 | $299.05 | 45,472.0000 | 48,500,000 | 1.09% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3392 | $301.81 | 40,760.0000 | 48,500,000 | 7.68% | 0.01% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3859 | $302.71 | 36,901.0000 | 48,500,000 | 9.47% | 0.01% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 120 | $303.38 | 36,781.0000 | 48,500,000 | 0.33% | 0.00% |
| May 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 15,000.0000 | 48,500,000 | 42.31% | 0.02% |
| April 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $117.76 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| April 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3096 | $284.69 | 36,781.0000 | 48,500,000 | 7.76% | 0.01% |
| April 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 400 | $280.35 | 47,381.0000 | 48,500,000 | 0.84% | 0.00% |
| April 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2016 | $282.92 | 45,365.0000 | 48,500,000 | 4.25% | 0.00% |
| April 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 5488 | $283.83 | 39,877.0000 | 48,500,000 | 12.10% | 0.01% |
| April 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 26,000.0000 | 48,500,000 | 29.73% | 0.02% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $300.42 | 47,381.0000 | 48,500,000 | 0.42% | 0.00% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $298.00 | 47,581.0000 | 48,500,000 | 0.42% | 0.00% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 11000 | $117.76 | 47,781.0000 | 48,500,000 | 29.91% | 0.02% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3787 | $307.12 | 38,282.0000 | 48,500,000 | 9.00% | 0.01% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2218 | $306.08 | 42,069.0000 | 48,500,000 | 5.01% | 0.00% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3094 | $305.08 | 44,287.0000 | 48,500,000 | 6.53% | 0.01% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Option | 11000 | $0.00 | 37,000.0000 | 48,500,000 | 22.92% | 0.02% |
| April 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1501 | $308.08 | 36,781.0000 | 48,500,000 | 3.92% | 0.00% |
| March 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 6550 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.01% |
| March 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 6550 | $307.68 | 36,781.0000 | 48,500,000 | 15.12% | 0.01% |
| March 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6550 | $163.30 | 43,331.0000 | 48,500,000 | 17.81% | 0.01% |
| Feb. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 6,550.0000 | 48,500,000 | 54.04% | 0.02% |
| Feb. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $367.36 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Feb. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Feb. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 14,250.0000 | 48,500,000 | 35.08% | 0.02% |
| Feb. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $353.75 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Feb. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Jan. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $366.39 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Jan. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 21,950.0000 | 48,500,000 | 25.97% | 0.02% |
| Jan. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Jan. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Jan. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $360.22 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Jan. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 29,650.0000 | 48,500,000 | 20.62% | 0.02% |
| Dec. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 37,350.0000 | 48,500,000 | 17.09% | 0.02% |
| Dec. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Dec. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $360.16 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Dec. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 7700 | $374.37 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Dec. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Dec. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 45,050.0000 | 48,500,000 | 14.60% | 0.02% |
| Nov. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 7700 | $367.36 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Nov. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Nov. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 52,750.0000 | 48,500,000 | 12.74% | 0.02% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $402.57 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 60,450.0000 | 48,500,000 | 11.30% | 0.02% |
| Oct. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 75,850.0000 | 48,500,000 | 9.22% | 0.02% |
| Oct. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Oct. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $350.07 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Oct. 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 48,500,000 | 20.98% | 0.02% |
| Oct. 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $372.81 | 36,710.0000 | 48,500,000 | 17.34% | 0.02% |
| Oct. 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 68,150.0000 | 48,500,000 | 10.15% | 0.02% |
| Sept. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 7700 | $351.33 | 36,710.0000 | 49,700,000 | 17.34% | 0.02% |
| Sept. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 7700 | $163.30 | 44,410.0000 | 49,700,000 | 20.98% | 0.02% |
| Sept. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 7700 | $0.00 | 83,550.0000 | 49,700,000 | 8.44% | 0.02% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | D | Common Stock | 25000 | $308.98 | 36,710.0000 | 49,700,000 | 40.51% | 0.05% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 25000 | $163.30 | 61,710.0000 | 49,700,000 | 68.10% | 0.05% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Share Tracking Award | 25000 | $0.00 | 91,250.0000 | 49,700,000 | 21.51% | 0.05% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Options | 6000 | $0.00 | 48,000.0000 | 49,700,000 | 11.11% | 0.01% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6000 | $117.76 | 42,710.0000 | 49,700,000 | 16.34% | 0.01% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 100 | $228.84 | 42,610.0000 | 49,700,000 | 0.23% | 0.00% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1374 | $230.99 | 41,236.0000 | 49,700,000 | 3.22% | 0.00% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3279 | $232.55 | 37,957.0000 | 49,700,000 | 7.95% | 0.01% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1041 | $233.64 | 36,916.0000 | 49,700,000 | 2.74% | 0.00% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 206 | $234.09 | 36,710.0000 | 49,700,000 | 0.56% | 0.00% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Options | 6000 | $0.00 | 54,000.0000 | 49,700,000 | 10.00% | 0.01% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6000 | $117.76 | 42,710.0000 | 49,700,000 | 16.34% | 0.01% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 857 | $234.11 | 41,853.0000 | 49,700,000 | 2.01% | 0.00% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 238 | $235.73 | 41,615.0000 | 49,700,000 | 0.57% | 0.00% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3505 | $236.71 | 38,110.0000 | 49,700,000 | 8.42% | 0.01% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1400 | $237.36 | 36,710.0000 | 49,700,000 | 3.67% | 0.00% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Options | 6000 | $0.00 | 60,000.0000 | 49,700,000 | 9.09% | 0.01% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6000 | $117.76 | 42,599.0000 | 49,700,000 | 16.39% | 0.01% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3000 | $236.90 | 39,599.0000 | 49,700,000 | 7.04% | 0.01% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2700 | $237.76 | 36,899.0000 | 49,700,000 | 6.82% | 0.01% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 300 | $238.85 | 36,599.0000 | 49,700,000 | 0.81% | 0.00% |
| Feb. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Options | 6000 | $0.00 | 66,000.0000 | 49,700,000 | 8.33% | 0.01% |
| Feb. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1088 | $216.04 | 36,599.0000 | 49,700,000 | 2.89% | 0.00% |
| Feb. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3362 | $215.43 | 37,687.0000 | 49,700,000 | 8.19% | 0.01% |
| Feb. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1550 | $214.54 | 41,049.0000 | 49,700,000 | 3.64% | 0.00% |
| Feb. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6000 | $117.76 | 42,599.0000 | 49,700,000 | 16.39% | 0.01% |
| Feb. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1200 | $213.58 | 41,399.0000 | 49,700,000 | 2.82% | 0.00% |
| Feb. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Options | 6000 | $0.00 | 72,000.0000 | 49,700,000 | 7.69% | 0.01% |
| Feb. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 400 | $216.37 | 36,599.0000 | 49,700,000 | 1.08% | 0.00% |
| Feb. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2799 | $215.72 | 36,999.0000 | 49,700,000 | 7.03% | 0.01% |
| Feb. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1601 | $214.53 | 39,798.0000 | 49,700,000 | 3.87% | 0.00% |
| Feb. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6000 | $117.76 | 42,599.0000 | 49,700,000 | 16.39% | 0.01% |
| Jan. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6000 | $117.76 | 42,599.0000 | 49,700,000 | 16.39% | 0.01% |
| Jan. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $222.60 | 36,599.0000 | 49,700,000 | 0.54% | 0.00% |
| Jan. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 200 | $221.02 | 36,799.0000 | 49,700,000 | 0.54% | 0.00% |
| Jan. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1899 | $219.30 | 36,999.0000 | 49,700,000 | 4.88% | 0.00% |
| Jan. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 2299 | $218.42 | 38,898.0000 | 49,700,000 | 5.58% | 0.00% |
| Jan. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1402 | $217.55 | 41,197.0000 | 49,700,000 | 3.29% | 0.00% |
| Jan. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Options | 6000 | $0.00 | 78,000.0000 | 49,700,000 | 7.14% | 0.01% |
| Jan. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 1710 | $227.34 | 40,889.0000 | 49,700,000 | 4.01% | 0.00% |
| Jan. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 3990 | $228.17 | 36,899.0000 | 49,700,000 | 9.76% | 0.01% |
| Jan. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | S | Common Stock | 300 | $228.83 | 36,599.0000 | 49,700,000 | 0.81% | 0.00% |
| Jan. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Stock Options | 6000 | $0.00 | 84,000.0000 | 49,700,000 | 6.67% | 0.01% |
| Jan. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | MAHON PAUL A | EVP & GENERAL COUNSEL | M | Common Stock | 6000 | $117.76 | 42,599.0000 | 49,700,000 | 16.39% | 0.01% |